Read the latest press releases for 4D pharma plc.
Click on a news title to read full details. For Regulatory News Service (RNS) announcements please click here.
Press release archive
8 Mar 2019, 09:00
4D announces participation in Chardan’s Inaugural Microbiome Medicines Summit, USA
29 Jan 2019, 09:00
4D pharma announces publication of data highlighting immuno-stimulatory properties of MRx0518
8 Jan 2019, 09:00
4D pharma plc announces the appointment of Ed Baracchini, PhD, and Professor Axel Glasmacher, MD, as…
7 Jan 2019, 09:00
4D pharma plc (AIM: DDDD) and The University of Texas MD Anderson Cancer Center today announced a…
8 Nov 2018, 12:00
4D pharma plc announces first patient enrolment in Blautix IBS Phase II study
24 Sep 2018, 15:56
4D pharma plc (AIM: DDDD), announces positive top-line results for its Phase Ib study of Thetanix in…
14 Aug 2018, 08:26
Data suggests that MRx0004 is a promising next-generation therapeutic for management of asthma
30 Jul 2018, 08:32
30 July 2018 -- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live…
27 Jun 2018, 08:35
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics,…
13 Jun 2018, 08:37
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics,…
7 Jun 2018, 08:38
4D pharma plc (AIM: DDDD), a clinical stage biopharmaceutical company, pioneering the development of…
4 Jun 2018, 11:45
4D pharma will present at the 2nd Annual Microbiome Discovery & Development Congress which takes…
4 Jun 2018, 08:44
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics,…
21 May 2018, 08:47
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics,…
10 May 2018, 12:49
4D pharma will participate in the Global Engage Microbiome Futures Conference in New York on May…
